Walleye Trading Advisors »

Unicycive Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Unicycive Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 292M2.5M3M3.5M4M4.999999M4.9999995M5M5.0000005M5.000001M
Value ($)Share countHistorical UNCY position of Walleye Trading Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.0M 5.0M 0.79
2024-09-30 $2.0M 5.0M 0.41

More positions owned by Walleye Trading Advisors

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Meta Platforms Cl A Call Option (META)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Netflix Call Option (NFLX)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)

View all positions for Walleye Trading Advisors

Top funds holding Unicycive Therapeutics

Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Octagon Capital Advisors
Vivo Capital
Logos Global Management
Walleye Trading Advisors
Silverarc Capital Management
Longwood Capital Partners
Alyeska Investment Group
Altium Capital Management
Vanguard Group
Geode Capital Management
XTX Topco
State Street Corporation
Goldman Sachs Group

View all funds holding Unicycive Therapeutics